Transforming Growth Factor Beta 2 (TGFb2)

TGF-B2; TGF-Beta2; G-TSF; LAP; Cetermin; Polyergin; Latency-associated peptide; BSC-1 cell growth inhibitor; Glioblastoma-derived T-cell suppressor factor

SPN	W526
HGNC	11768
MGI	98726
PubMed	22772371
RGD	70491
UniProt	P61812
Wiki	TGFB2

TGFB2 is present at elevated levels in the aqueous humor of patients with primary open angle glaucoma (POAG). Studies have shown that TGFB2 influences cultured trabecular meshwork cells.TGFB2 reduced outflow facility when perfused into cultured human anterior segments. Furthermore, TGFB2 affected the extracellular matrix of the trabecular meshwork in a manner that was consistent with the observed reduction in outflow facility. Although the distribution of accumulated fibrillar material was different in these perfused eyes than that in POAG, the difference could have been due to variation in biomechanical environment for trabecular meshwork cells in cultured anterior segments compared with the living eye. elevated TGFB2 levels in the aqueous humor played a role in the pathogenesis of the ocular hypertension in POAG.

Reference

"Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family."
EMBO J. 6:3673-3677(1987) [PubMed] [Europe PMC] [Abstract]

"Transforming growth factor-beta 2: cDNA cloning and sequence analysis."
DNA 7:1-8(1988) [PubMed] [Europe PMC] [Abstract]

"Structural and sequence analysis of TGF-beta 2 cDNA clones predicts two different precursor proteins produced by alternative mRNA splicing."
DNA 7:493-497(1988) [PubMed] [Europe PMC] [Abstract]

"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"Molecular cloning and structure of the human transforming growth factor-beta 2 gene promoter."
Growth Factors 4:247-255(1991) [PubMed] [Europe PMC] [Abstract]

"Complete amino acid sequence of human transforming growth factor type beta 2."
J. Biol. Chem. 262:12127-12131(1987) [PubMed] [Europe PMC] [Abstract]

"Molecular characterization of a familial translocation implicates disruption of HDAC9 and possible position effect on TGFbeta2 in the pathogenesis of Peters' anomaly."
Genomics 81:489-503(2003) [PubMed] [Europe PMC] [Abstract]

"Mechanisms for asporin function and regulation in articular cartilage."
J. Biol. Chem. 282:32185-32192(2007) [PubMed] [Europe PMC] [Abstract]

"Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily."
Science 257:369-373(1992) [PubMed] [Europe PMC] [Abstract]

"An unusual feature revealed by the crystal structure at 2.2-A resolution of human transforming growth factor-beta 2."
Nature 358:430-434(1992) [PubMed] [Europe PMC] [Abstract]

"Two novel polymorphisms in the human transforming growth factor beta 2 gene."
Genes Immun. 2:295-296(2001) [PubMed] [Europe PMC] [Abstract]

"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm."
Nat. Genet. 44:922-927(2012) [PubMed] [Europe PMC] [Abstract]

"Whole exome sequencing for the identification of a new mutation in TGFB2 involved in a familial case of non-syndromic aortic disease."
Clin. Chim. Acta 437:88-92(2014) [PubMed] [Europe PMC] [Abstract]